Risk factors for a broken heart: understanding drug-induced causes for Takotsubo syndrome and pharmacological treatment options.
Gao Jing OngThanh Ha NguyenSven Y SurikowChukwudiebube N AjaeroPublished in: Expert review of clinical pharmacology (2022)
-adrenoceptor stimulation, increased responsiveness to NO and triggering of activation of poly(ADP-ribose) polymerase (PARP). In theory, interruption of this 'cascade' represents a logical approach to improving both symptomatic status and survival post TTS. Currently, there is some evidence supporting routine long-term treatment post TTS with either ACE inhibitors or angiotensin receptor antagonists, both to reduce risk of recurrence and to improve survival. Results of ongoing controlled clinical trials are awaited.